SEC Form 4 · accession 0001209191-18-020344
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — Chief Medical Officer
Period of report
Mar 14, 2018
Accepted (ET)
Mar 16, 2018 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2018 | S | 9,891 | $53.20 | D | 128,333 | D | |
| Common StockF2 | Mar 14, 2018 | A | 32,000 | $0.00 | A | 160,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $53.75 | Mar 14, 2018 | A | 55,000 | A | — | Mar 14, 2028 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2019, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- F3Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.